Last week, it was revealed that welterweight contender Conor Benn was cleared of doping charges by UK Anti-Doping [UKAD].
Back in April, Benn was suspended and formally charged by UKAD after twice testing positive for the banned substance clomifene in connection to last October’s fight with Chris Eubank Jr.
Benn and Eubank were scheduled to collide in a high-stakes fight, but the bout was called off during fight week when news broke that Benn had tested positive for a banned substance on a drug test administered by VADA. Benn would later reveal that he tested positive for the same substance in an earlier test.
The British Boxing Board of Control refused to sanction Benn-Eubank, which led to the event’s cancelation.
On Monday, the BBBofC issued an official statement – where the organization revealed the possibility of appealing UKAD’s decision on Benn.
“The British Boxing Board of Control (BBBofC) is aware that Mr Benn and UK Anti-Doping (UKAD) have provided public comment in relation to confidential proceedings before the independent National Anti-Doping Panel,” said the British Boxing Board of Control in a statement.
“The BBBofC is not able to comment on the proceedings between UKAD and Mr Benn due to confidentiality restrictions. We refer to the statement issued by UK Anti-Doping [located on their website]
“As set out therein, we wish to reconfirm that the UK Anti-Doping Rules which apply to those proceedings provide all relevant parties, including the BBBofC, with a right of appeal. The BBBofC takes all anti-doping matters extremely seriously and is considering the exercise of its rights pursuant to the Rules.
“Further comment will not be provided pending conclusion of the UKAD process in full due to the confidentiality restrictions in place. All enquiries should be directed to UKAD, as the body responsible for the enforcement of the Rules.”